PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry

The UK has an incredible opportunity to improve patients’ lives through cannabis-based medicines for some of the most debilitating conditions, such as chronic pain.
Celadon Pharmaceuticals Plc is at the forefront of building this new pharmaceutical sector. We have a simple approach: high-quality UK cultivation and API manufacturing, clinical trials, and R&D into cannabinoids.
We need others in this journey – regulators, universities, pharmaceutical companies, and the government. The prize is worth it: patients’ quality of life across the UK.
Continue reading on City AM by Clicking Here.
OTHER POSTS
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
BUSINESS UPDATE: Celadon Pharmaceuticals Plc (CEL) Announces Interim Results
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches
-
PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework